NLR And LMR Were Independent Predictors Of 1-Year Mortality In Patients With Cirrhosis-Associated HCC, Study Finds

Rare Disease Advisor (6/10, Garlapow) reports, “Neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) were independent predictors of 1-year mortality in patients with cirrhosis-associated hepatocellular carcinoma (HCC), according to a study.” Investigators found that “NLR outperformed other noninvasive serum-based indices.” The data indicated that “a novel nomogram that integrates these markers alongside clinical variables demonstrated strong prognostic utility, with a concordance index of 0.808...for 12-month mortality.” The findings were published in the Journal of Clinical and Experimental Hepatology.